Printer Friendly

DIANON SYSTEMS, INC. AND DIAGNOSTIC TECHNOLOGIES, INC. COMBINE TO EVALUATE PREGNANCY MONITORING PROCEDURE

 -- Evaluation Of New High Risk Pregnancy Marker --
 STRATFORD, Conn., Jan. 12 /PRNewswire/ -- DIANON Systems, Inc.


(NASDAQ: DIAN) announced today that an agreement has been reached with Diagnostic Technologies, (Los Angeles, Calif.) giving DIANON exclusive commercial rights to novel proprietary technology to monitor the progress of a pregnancy in the third trimester.
 The United States ranks 22nd in the industrialized nations for infant mortality. In large part, this is a consequence of three conditions, spontaneous preterm labor, intrauterine growth restriction, and preeclampsia. Scientists at Diagnostic Technologies have developed a laboratory test which appears to be able to detect these three conditions in a pregnancy prior to the onset of symptoms, while therapy options are still available.
 Currently there are no available technologies which can predict which women are at higher risk for any of these conditions, though there are monitoring devices for use once symptoms develop. The procedure developed by Diagnostic Technologies and to be evaluated by DIANON's laboratory, appears to predict which pregnancies are high risk at a point when intervention may be beneficial.
 DIANON will be incorporating this marker into its pregnancy monitoring research program with the intent of beginning clinical trials in 1993.
 Diagnostic Technologies and its sister company, Procreative Technologies, are engaged in the development of products and services used by OB/GYN's and urologists. Among the company's products/services are a line of infertility diagnostic assays, andrology laboratories, and sperm banks. The company is currently conducting R&D aimed at developing assays for the detection of ovarian, endometrial and uterine cancer.
 -0- 1/12/93
 /CONTACT: Richard A. Sandberg, chairman and co-chief executive officer of DIANON Systems, Inc., 203-381-4022, or Gabriel Deutsch, president of Procreative Technologies, Inc., 310-203-5453/
 (DIAN)


CO: DIANON Systems, Inc.; Diagnostic Technologies ST: Connecticut, California IN: MTC SU:

LD -- NY112 -- 4256 01/12/93 18:31 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 12, 1993
Words:304
Previous Article:DIANON SYSTEMS, INC. AND SCANTIBODIES COMBINE TO IMPROVE CLINICAL TESTING SERVICES
Next Article:DIANON SYSTEMS, INC. AND BIS LABORATORIES TO EVALUATE NEW CANCER CELL DETECTION METHOD
Topics:


Related Articles
DIANON SYSTEMS REPORTS INCREASE IN FOURTH-QUARTER SALES
DIANON SYSTEMS SELECTED AS ANALYST'S NO. 1 HEALTH CARE COMPANY AT THE HAMBRECHT & QUIST HEALTH CARE CONFERENCE
DIANON SYSTEMS REPORTS FOURTH QUARTER SALES AND EARNINGS
DIANON SYSTEMS, INC. TO SUPPORT MARKET INTRODUCTION OF NEW IMAGING TECHNOLOGY
DIANON SYSTEMS, INC. AND SCANTIBODIES COMBINE TO IMPROVE CLINICAL TESTING SERVICES
DIANON SYSTEMS, INC. AND BIS LABORATORIES TO EVALUATE NEW CANCER CELL DETECTION METHOD
DIANON SYSTEMS, INC. ANNOUNCES THE PURCHASE OF COLLABORATIVE DIAGNOSTICS
DIANON SYSTEMS, INC. REPORTS FIRST QUARTER SALES AND EARNINGS
DIANON Systems, Inc. Proposes A Business Combination With UroCor, Inc.
DIANON to Offer Hybrid Capture(R) 2 HPV Test and Automatic Reflex Testing For ASCUS Triage.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters